Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Bacteria, which are susceptible to infection by bacteriophages, often carry multiple genes encoding anti-phage defense ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

Only one reliable treatment for the sexually transmitted infection still exists, because the bacteria that cause it have ...

Felix Deschner, Dietrich Mostert, Jan-Martin Daniel et al.: Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets. Cell Chemical Biology. 2025. DOI: ...

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

An antibiotic that is commonly used for urinary tract infections effectively treated gonorrhoea, and may even work against ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

HPGDS enzyme plays key role in resistance of immunotherapy in various cancers  Up to 65% of patients with melanoma do not ...

Drug-resistant bacteria are one of the most urgent threats in modern medicine. But scientists are looking to oysters for help ...